Appointment of Secretarial Auditor
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Welcure Drugs & Pharmaceuticals has informed the BSE that its Board of Directors, at a meeting held on 29 May 2025, approved the appointment of Vishakha Agrawal & Associates, Practicing Company Secretaries, as Secretarial Auditors for the financial year 2024-25. Vishakha Agrawal is a Practicing Company Secretary with experience in company law, securities laws, and secretarial audits. The disclosure was made under SEBI Listing Regulations. The intimation was signed by Chintan Didawala Ganpat, who serves as both Managing Director and CFO of the company.
This is a routine regulatory disclosure appointing a secretarial auditor for the current financial year. No material impact on shareholders or stock price is expected, as secretarial audit is a standard compliance requirement for listed companies.